Leaders of a key US Senate health committee are expected to grill incoming President Donald Trump's pick for Health and Human Services Secretary, Rep. Tom Price, R-Ga., this week about his investments in health-care firms over the past year, including in the orthopedic device firm Zimmer Biomet Holdings Inc.
Among the issues that have been raised is that the HHS Secretary-nominee purchased between $1,001 to $15,000 worth of Zimmer Biomet shares in March 2016, according to congressional records, about the same time he introduced H.R. 4848, the Healthy Inpatient Procedures (HIP) Act (Also see "Fierce Critic Of Obamacare, Medicare Delivery Reforms Tapped To Run HHS" - Medtech Insight, 29 November, 2016.), which calls for a delay in CMS's
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?